| 000 | 01377 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514184303.0 | ||
| 264 | 0 | _c20040507 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a0005-0423 | ||
| 024 | 7 |
_a10.1111/j.1751-0813.2003.tb12498.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBraddock, J A | |
| 245 | 0 | 0 |
_aTrilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. _h[electronic resource] |
| 260 |
_bAustralian veterinary journal _cOct 2003 |
||
| 300 |
_a600-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_a3-Hydroxysteroid Dehydrogenases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAdrenocortical Hyperfunction _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDihydrotestosterone _xadministration & dosage |
| 650 | 0 | 4 |
_aDog Diseases _xblood |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChurch, D B | |
| 700 | 1 | _aRobertson, I D | |
| 700 | 1 | _aWatson, A D J | |
| 773 | 0 |
_tAustralian veterinary journal _gvol. 81 _gno. 10 _gp. 600-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1751-0813.2003.tb12498.x _zAvailable from publisher's website |
| 999 |
_c14794083 _d14794083 |
||